Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Formulary Rules Will Be Sorted Out By Courts, Kaiser Says

Executive Summary

Medicare drug formulary rules are likely to be challenged in court after the Centers for Medicare & Medicaid Services issues final regulations for the prescription drug benefit, Kaiser Foundation Health Plan Senior Counsel-Government Relations Anthony Barrueta predicted

You may also be interested in...



Formulary Balancing Act: Medicare Rules Weigh Access Versus Cost Control

The Medicare prescription drug benefit implementing regulations would require formularies to contain at least two drugs in every therapeutic class

Formulary Balancing Act: Medicare Rules Weigh Access Versus Cost Control

The Medicare prescription drug benefit implementing regulations would require formularies to contain at least two drugs in every therapeutic class

Medicare Formularies Will Have Two Drugs Per Class; CMS To Track Atypicals

Medicare prescription drug plan formularies will have at least two drugs in each class, CMS Administrator-designate Mark McClellan says

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS043497

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel